Report No. 11A print friendly version of this report is available as a PDF (288 KB)
Week ending 19 August 2011
The Department of Health and Ageing acknowledges the providers of the many sources of data used in this report and greatly appreciates their contribution.
Key IndicatorsInfluenza activity and severity in the community is monitored using the following indicators and surveillance systems:
|Is the situation changing?||Indicated by trends in:
|How severe is the disease, and is severity changing?||Indicated by trends in:
|Is the virus changing?||Indicated by trends in:
- Levels of influenza-like illness (ILI) in the community continued to increase through both sentinel general practitioner surveillance systems and ILI presentations to emergency departments.
- Notifications have decreased in Queensland, New South Wales and South Australia, but have continued to increase in all other states and territories. Nationally the number of notifications has decreased in recent weeks. Currently the weekly number of notifications in the ACT, New South Wales, Queensland and Tasmania remain above the peak frequency of notifications observed in 2010.
- During this reporting period there were 3,096 laboratory confirmed notifications of influenza, with Queensland reporting the highest number of notifications, followed by New South Wales and South Australia. Nationally, the majority of virus detections have been pandemic (H1N1) 2009, with co-circulation of influenza B.
- The majority of states and territories have predominately reported pandemic (H1N1) 2009, with co-circulation of influenza B, except in Tasmania where there is mostly influenza B, and in Western Australia where there is mostly pandemic (H1N1) 2009, some A/H3N2 and very little influenza B.
- As at 19 August 2011, there have been 16,990 confirmed cases of influenza reported to the National Notifiable Diseases Surveillance System (NNDSS) in 2011. Currently the weekly number of notifications being reported nationally is above the peak frequency experienced in previous years, except 2009.
- The WHO Collaborating Centre have reported a recent cluster of influenza viruses showing resistance to oseltamivir, all have been the pandemic (H1N1) 2009 subtype.
- The WHO has reported that influenza activity in the temperate regions of the northern hemisphere remains low. Influenza transmission continues to occur in a few countries of the tropical region. After peaking in early June, influenza transmission in South Africa has declined to low levels. In New Zealand, rates of national ILI consultations have recently declined to below baseline activity levels and influenza type B is currently the predominant strain circulating.
1. Influenza activity in Australia
Sentinel General Practice SurveillanceSentinel general practitioner ILI consultation rates have continued to increase. In the week ending 14 August 2011, the national ILI consultation rate to sentinel GPs was 15 cases per 1,000 consultations, a similar consultation rate to the previous fortnight (Figure 1).
Figure 1. Weekly rate of ILI reported from GP ILI surveillance systems from 1 January 2008 to 14 August 2011*
* Delays in the reporting of data may cause data to change retrospectively. As data from the VIDRL surveillance system is combined with ASPREN data for 2010 and 2011, rates may not be directly comparable across 2008 and 2009.
SOURCE: ASPREN and VIDRL GP surveillance system1.
In the fortnight ending 14 August 2011, specimens were collected from almost 46% of ASPREN ILI patients. Of these patients, 72 specimens (39%) were positive for influenza, which is an increase from the proportion that were positive in the previous fortnight. Forty-four specimens were typed as influenza type A, and were mostly pandemic (H1N1) 2009; and the remainder (28) were influenza type B. Forty-one specimens were positive for other respiratory viruses, with the majority of these being respiratory syncytial virus (15) (Table 1).
Table 1. ASPREN ILI consultations laboratory respiratory viral tests that were positive for influenza or other respiratory virus, 1 January 2011 to 31 July 2011.
(18-31 July 2011)
(1 Jan – 31 July 2011)
|Total specimens tested|
|Total Influenza Positive|
|Pandemic (H1N1) 2009|
|Influenza A untyped|
|Total Positive other Resp. Viruses*|
* Other respiratory viruses include RSV, para-influenza, adenovirus and rhinovirus.
Western Australia Emergency DepartmentsIn the fortnight ending 21 August 2011, respiratory viral presentations to WA EDs increased, and presentations continued to be above baseline levels. Over this period there were 1,263 presentations, including 86 admissions (Figure 2). The proportion of presentations admitted to hospital over this period remained stable and represented 7% of presentations.
Figure 2. Number of respiratory viral presentations to WA EDs from 1 January 2008 to21 August 2011, by week
Source: WA ‘Virus Watch’ Report2
New South Wales Emergency DepartmentsIn the week ending 19 August 2011 the rate of ILI presentations to NSW EDs was 2.3 cases per 1,000 presentations (Figure 3). This is slightly lower than the previous week’s rate (2.8 per 1,000 presentations). A high proportion of presentatio.ns were reported among people aged 5 to 44 years (72%). Total admissions to critical care units continued at a similar rate to the previous week and remained within the usual range for this time of year3.
Top of Page
Figure 3. Rate of influenza-like illness presentations to NSW Emergency Departments between May and October, 2008 to 2011, by week
Source: NSW Influenza Weekly Epidemiology Report3
FluTrackingFluTracking, a national online system for collecting data on ILI in the community, reported that in the week ending 21 August 2011 fever and cough was reported by 3.1% of vaccinated participants and 3.7% of unvaccinated participants (Figure 4) 4. Fever, cough and absence from normal duties was reported by 1.7% of vaccinated participants and 1.7% of unvaccinated participants.
Up to 21 August 2011, 5,652 out of 10,137 (55.8%) participants reported having received the seasonal vaccine so far. Of the 2,315 participants who identified as working face-to-face with patients, 1,689 (73.0%) have received the vaccine.
Figure 4. Rate of ILI symptoms among Flutracking participants by week, from week ending 8 May 2011 to week ending 21 August 2011.
National Health Call Centre NetworkThe number of ILI-related calls to the National Health Call Centre Network (NHCCN) remained relatively stable compared to the previous fortnight. The percentage of total calls also remained relatively stable. In the week ending 21 August 2011, 9% of calls to the NHCCN were ILI related, which is above the same period in 2010 (Figure 5).
Figure 5. Number of calls to the NHCCN related to ILI and percentage of total calls, Australia, 1 January 2010 to 21 August 2011
Note: National data do not include QLD and VIC
Source: NHCCN data
Top of Page
Laboratory Confirmed Influenza
Laboratory Confirmed Cases Notified to Health DepartmentsDuring this reporting period there were 3,096 laboratory confirmed influenza notifications reported to the NNDSS. Of these notifications, there were 1,485 in Qld, 530 in NSW, 508 in SA, 303 in Vic, 171 in WA, 47 in TAS, 35 in the ACT, and 17 in the NT (Figure 6). A weekly breakdown of trends by state and territory highlights that notifications have continued to be highest in Queensland, New South Wales and South Australia, however in recent weeks the number of notifications within these states appears to be decreasing. Increases are being observed in all other states and territories. The weekly number of influenza notifications currently being reported in the ACT, New South Wales, Queensland and Tasmania are higher than the peak frequency experienced in 2010 (Figure 8).
Figure 6. Laboratory confirmed cases of influenza in Australia, 1 January to 19 August 2011, by state, by week.
Source: NNDSS 2011
Up to 19 August, there have been 16,990 laboratory confirmed notifications of influenza diagnosed during 2011 (Figure 7). Of these notifications, there have been 7,611 notified in Qld, 3,661 in NSW, 2,813 in SA, 1,377 in Vic, 755 in WA, 373 in the NT, 210 in Tas and 190 in the ACT. Currently the weekly number of notifications being reported nationally is above the peak frequency experienced in previous years, except 2009. Over the summer months, all jurisdictions reported higher than usual numbers of notifications, especially in the Northern Territory and Queensland. The reason for this unusually high activity is not clear, but it does not appear to be due solely to increased testing.
Figure 7. Laboratory confirmed cases of influenza in Australia, 1 January 2005 to 19 August 2011
Source: NNDSS 2011
Figure 8. State breakdowns of laboratory confirmed cases of influenza, 1 January to 19 August 2011, by week
Source: NNDSS 2011
Of the 3,096 influenza notifications reported to the NNDSS this reporting period, 1,926 were influenza A (1,030 were influenza A (untyped), 857 were pandemic (H1N1) 2009 and 39 were A/H3N2), 1,161 were influenza B, 4 were influenza A and B and 5 notifications were reported as untyped (Figure 9). Compared to the beginning of the year, there appears to be very little A/H3N2 circulating.
Top of Page
In recent weeks the proportion of influenza B in South Australia has continued to decline and currently represents 43% of their notifications, with the remainder being mostly pandemic (H1N1) 2009. The majority of states and territories have reported mostly pandemic (H1N1) 2009, with co-circulation of influenza B. However, in Tasmania influenza B is the dominant strain, and in Western Australia there is very little influenza B circulating and of the small number of A/H3N2 notifications nationally these are also mostly from Western Australia.
So far in 2011, 5,912 (35%) cases have been sub-typed as influenza A (untyped), 5,473 (32%) as pandemic (H1N1) 2009, 889 (5%) as type A/H3N2, and 53 (<1%) were type A&B. A further 4,604 (27%) have been characterised as influenza type B and 59 (<1%) were untyped (Figure 9).
Note: Northern Territory sub-typing results reported to the NNDSS as "Influenza A/Not Pandemic" have been counted as influenza A/H3N2 notifications.
Figure 9. Laboratory confirmed cases of influenza in Australia, 1 January 2011 to 19 August 2011, by sub-type and week
Source: NNDSS 2011
Sentinel Laboratory SurveillanceResults from sentinel laboratory surveillance systems for this reporting period show that 15.4% (276/1,789) of the respiratory tests conducted over this period were positive for influenza (Table 2). Positive influenza specimens were reported from all sentinel laboratories.
Table 2. Sentinel laboratory respiratory testing results, 23 July to 5 August 2011
|NSW NIC||WA NIC||NT|
(Reported by WA NIC)
PCR Testing Data
|Total specimens tested|
|Total Influenza Positive|
|Positive Influenza A|
|Pandemic (H1N1) 2009|
|Influenza A untyped|
|Positive Influenza B|
|The most common respiratory virus detected||Influenza & Rhinovirus||Influenza A||-||Picornavirus||RSV|
Figure 10. Proportion of sentinel laboratory* tests positive for influenza, by subtype and fortnight, 30 April to 19 August 2011.
* Tasmanian PCR testing data included from 9 July 2011
Influenza Complications Alert Network (FluCAN) – Victoria and the Australian Capital Territory
The Influenza Complications Alert Network (FluCAN) sentinel hospital system in Victoria, South Australia, Western Australia and the ACT has reported 88 hospitalisations, including seven ICU admissions, associated with influenza since 1 May 2011. Over half of the hospitalisations and 71% of ICU admissions have been associated with pandemic (H1N1) 2009 infection. The mean age of patients hospitalised has been 47.3 years.
Figure 11. Number of influenza hospitalisations at sentinel hospitals, Victoria, South Australia, Western Australia and the ACT, by week and influenza subtype, 1 May to 18 August 2011
Source: FluCAN Sentinel Hospitals
Australian Paediatric SurveillanceThe Australian Paediatric Surveillance Unit (APSU) conducts seasonal surveillance of children aged 15 years and under who are hospitalised with severe complications of influenza. Between 1 July and 22 August 2011, there have been 24 hospitalisations associated with severe influenza complications in children, including 9 ICU admissions. The majority of these hospitalisations were associated with pandemic (H1N1) 2009 infection. Of the 19 hospitalisations with completed questionnaires, 7 were noted as having underlying chronic medical conditions.
Deaths associated with influenza and pneumonia
Nationally Notified Influenza Associated DeathsIn 2011, 11 influenza associated deaths have been notified to the NNDSS, with a median age of 53 years. Eight of these cases were reported as having a pandemic (H1N1) 2009 infection, two with influenza type B and the other case reported as having influenza type A (untyped).
Top of Page
New South Wales Influenza and Pneumonia Death RegistrationsDeath registration data up to 5 August 2011 showed that there were 1.4 pneumonia or influenza associated deaths per 100,000 population in NSW, which is below the seasonal threshold of 1.8 per 100,000 NSW population for this period (Figure 12).3
Figure 12. Rate of deaths classified as influenza and pneumonia from the NSW Registered Death Certificates, 2006 to 5 August 2011
Source: NSW ‘Influenza Weekly Epidemiology Report’3
Typing and antigenic characterisation
WHO Collaborating Centre for Reference & Research on Influenza (WHO CC) in MelbourneFrom 1 January to 21 August 2011, there were 1,288 Australian influenza isolates subtyped by the WHO CC with almost half of these isolates subtyped as pandemic (H1N1) 2009 (47%) (Table 3).
Table 3. Typing of influenza isolates from the WHO Collaborating Centre, from 1 January 2011 to 21 August 2011
|Pandemic (H1N1) 2009|
SOURCE: WHO CC
Please note: There may be up to a month delay on reporting of samples.
Isolates tested by the WHO CC are not necessarily a random sample of all those in the community
Antigenic characterisation has shown influenza isolates to be a close match with the composition of the 2011 southern hemisphere influenza vaccine with some viruses showing reduced reactivity, however there has been insufficient testing to date to determine any general trends.
Antiviral ResistanceThe WHO Collaborating Centre in Melbourne has reported that from 1 January 2011 to 21 August 2011, 12 isolate (out of 1,291 tested) has shown resistance to oseltamivir by enzyme inhibition assay (EIA). A further 7 isolates, out of a total of 57 tested by pyrosequencing, has shown the H275Y mutation known to confer resistance to oseltamivir. A total of 19 influenza viruses have shown resistance to oseltamivir, all have been the pandemic (H1N1) 2009 subtype. The recent increases in oseltamivir resistance in pandemic (H1N1) 2009 influenza isolates has occurred in the Newcastle region of New South Wales and predominately between June and August 2011. New South Wales Health are investigating this cluster of cases.
Top of Page
3. International Influenza SurveillanceThe WHO5 has reported that as at 12 August 2011 influenza activity in the temperate regions of the northern hemisphere remains low or undetectable. In the tropical zone, influenza activity is low, with some transmission reported in countries of the Americas (Dominican Republic, Columbia; and Brazil); western Africa (Ghana and Cameroon); and southern Asia (India, Bangladesh, Thailand and Singapore). Influenza transmission in South Africa has declined to low levels, after peaking in early to mid June. Viral transmission within South Africa was dominated by pandemic A(H1N1) 2009, with smaller numbers of influenza type B.
In New Zealand6, for the week ending 21 August 2011, the national rate of ILI consultations are now slightly below the baseline activity levels with half of the twenty district health boards above the national average weekly consultation rate. Influenza type B continues to be the predominant strain followed by influenza A(H3N2).
National Influenza Centres in 52 countries have reported that for the period 17 to 30 July 2011, a total of 1,009 specimens were reported as positive for influenza viruses, 685 (68%) were typed as influenza A and 324 (32%) as influenza B. Of the sub-typed influenza A viruses reported, 52% were pandemic (H1N1)2009 and 48% were influenza A(H3N2) 7.
WHO have released a summary review of the northern hemisphere winter influenza season8. The summary review notes that the most commonly detected virus was different in North America, where influenza A(H3N2) and influenza type B co-circulated with pandemic (H1N1) 2009, and Europe, where influenza A(H1N1)2009 was by far the most commonly detected virus. Although it was no longer the predominant influenza virus circulating in many parts of the world, pandemic (H1N1) 2009 otherwise behaved much the same way as it had during the pandemic in terms of the age groups most affected and the clinical pattern of illness. More than 90% of viruses detected around the world during the northern hemisphere influenza season were similar antigenically to those found in the seasonal trivalent influenza vaccine. Antiviral resistance in pandemic (H1N1)2009 remained at a very low level.
The WHO has released their recommendation for the antigen composition of 2011-2012 northern hemisphere influenza season trivalent flu vaccine9. It is recommended that vaccines contain the following:
- an A/California/7/2009 (H1N1)-like virus;
- an A/Perth/16/2009 (H3N2)-like virus;
- a B/Brisbane/60/2008-like virus.
4. Data considerationsThe information in this report is reliant on the surveillance sources available to the Department of Health and Ageing. As access to sources increase as the season progresses, this report will be updated with the additional information.
This report aims to increase awareness of pandemic (H1N1) 2009 and seasonal influenza in Australia by providing an analysis of the various surveillance data sources throughout Australia. While every care has been taken in preparing this report, the Commonwealth does not accept liability for any injury or loss or damage arising from the use of, or reliance upon, the content of the report. Delays in the reporting of data may cause data to change retrospectively. For further details about information contained in this report please contact the Influenza Surveillance Team through email@example.com.
Sentinel General Practice SurveillanceThe Australian Sentinel Practices Research Network (ASPREN) has Sentinel GPs who report ILI presentation rates in NSW, NT, SA, ACT, VIC, QLD, TAS and WA. As jurisdictions joined ASPREN at different times and the number of GPs reporting has changed over time, the representativeness of ASPREN data in 2011 may be different from that of previous years. ASPREN data and VIDRL influenza surveillance data are sent to the Department on a weekly basis. Approximately 30% of all ILI patients presenting to ASPREN sentinel GPs are swabbed for laboratory testing. Please note the results of ASPREN ILI laboratory respiratory viral tests now include Western Australia.
Further information on Sentinel GPs’ Influenza Surveillance and ASPREN activities are available at www.dmac.adelaide.edu.au/aspren.
Sentinel Emergency Department DataWA - ED surveillance data are extracted from the ‘Virus Watch’ Report. This report is provided weekly. The Western Australia Influenza Surveillance Program collects data from eight Perth EDs.
NSW - ED surveillance data are extracted from the ‘Weekly Influenza Report, NSW’. The New South Wales Influenza Surveillance Program collects data from 56 EDs across New South Wales.
FluTrackingFluTracking is a project of the University of Newcastle, the Hunter New England Area Health Service and the Hunter Medical Research Institute. FluTracking is an online health surveillance system to detect epidemics of influenza. It involves participants from around Australia completing a simple online weekly survey, which collects data on the rate of ILI symptoms in communities.
Further information on FluTracking is available at www.flutracking.net/index.html.
National Notifiable Diseases Surveillance System (NNDSS)Laboratory confirmed influenza (all types) is notifiable under public health legislation in all jurisdictions in Australia. Confirmed cases of influenza are notified through the NNDSS by all jurisdictions. The national case definition is available at: http://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_flu.htm.
Analyses of Australian cases are based on the diagnosis date, which is the earliest of the onset date, specimen date or notification date.
Sentinel Laboratory Surveillance dataLaboratory testing data are provided weekly directly from PathWest (WA), VIDRL (VIC), ICPMR (NSW), Tasmanian laboratories reporting PCR results, and ASPREN (national).
Top of Page
Influenza Complications Alert Network (FluCAN)The Influenza Complications Alert Network (FluCAN) sentinel hospital system monitors influenza hospitalisations at the following sites:
- Victoria – Geelong Hospital, Royal Melbourne Hospital, Monash Medical Centre and Alfred Hospital;
- Australian Capital Territory – Canberra Hospital and Calvary Hospital;
- South Australia – Royal Adelaide Hospital;
- Western Australia – Royal Perth Hospital.
Australian Paediatric Surveillance UnitThe Australian Paediatric Surveillance Unit (APSU) conducts seasonal surveillance of children aged 15 years and under who are hospitalised with severe complications of influenza. Reports are collated on a weekly basis from approximately 1,300 paediatricians and other child health clinicians around Australia. The protocol and case definition is available at:
WHO Collaborating Centre for Reference & Research on Influenza (WHO CC)Data are provided weekly to the Health Protection and Surveillance Branch from the WHO CC.
Deaths associated with influenza and pneumoniaNationally reported influenza associated deaths are notified by jurisdictions to the NNDSS which is maintained by the Department of Health and Ageing. However these are an underestimation of the true number of deaths occurring in the community associated with influenza.
NSW influenza and pneumonia deaths data are collected from the NSW Registry of Births, Deaths and Marriages. Figure 12 is extracted from the ‘Weekly Influenza Report, NSW’. NSW Registered Death Certificates are routinely reviewed for deaths attributed to pneumonia or influenza. While pneumonia has many causes, a well-known indicator of seasonal and pandemic influenza activity is an increase in the number of death certificates that mention pneumonia or influenza as a cause of death. The predicted seasonal baseline estimates the predicted rate of influenza or pneumonia deaths in the absence of influenza epidemics. If deaths exceed the epidemic threshold, then it may be an indication that influenza is beginning to circulate widely.
Top of Page
5. References1 The 2011 Victorian Influenza Vaccine Effectiveness Audit Report #116, 21 August 2011. Available from: www.victorianflusurveillance.com.au. Accessed 25 August 2011.
2 WA Virus Watch Report, 21 August 2011. Available from: http://www.public.health.wa.gov.au/3/487/3/virus_watch.pm. Accessed 26 August 2011.
3 NSW Influenza Weekly Epidemiology Report, 13 to 19 August 2011. Available from: http://www.health.nsw.gov.au/resources/publichealth/infectious/influenza/pdf/week_ending_19082011.pdf, Accessed 26 August 2011.
4 Flutracking Weekly Interim Report #16, 21 August 2011. Available from: http://www1.hnehealth.nsw.gov.au/hneph/HNEPHApplications/FluSurvey/Reports/LatestReport.pdf. Accessed 26 August 2011.
5 WHO Weekly Influenza Update 140 (12 August 2011). Available from: http://www.who.int/csr/disease/influenza/latest_update_GIP_surveillance/en/index.html#. Accessed 26 August 2011.
6 New Zealand Influenza Weekly Update, Week Ending 21 August 2011. Available from: http://www.surv.esr.cri.nz/virology/influenza_weekly_update.php, Accessed 25 August 2011.
7 WHO Laboratory confirmed data from the Global Influenza Surveillance Network – 12 August 2011. Available from: http://www.who.int/csr/disease/influenza/influenzanetwork/flunet/summaryreport/en/index.html. Accessed 26 August 2011.
8 WHO Summary review of the 2010-2011 northern hemisphere winter influenza season. Available from: http://www.who.int/csr/disease/influenza/2010_2011_GIP_surveillance_seasonal_review/en/index.html. Accessed 16 June 2011.
9 WHO Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Available from: http://www.who.int/csr/disease/influenza/recommendations_2011_12north/en/index.html. Accessed 3 June 2011.